“Protect your lungs: get vaccinated.” Breathe 2019; 15: 263–264.
Breathe, 15 (4) 358; 10.1183/20734735.ELF553 | |
Biomarkers in respiratory diseases Claudia C. Dobler Breathe, 15 (4) 265; 10.1183/20734735.0329-2019 | |
Advanced roles in respiratory healthcare science: it's not just spirometry Joanna Shakespeare, Edward Parkes, Melanie Bryce, James Hull Breathe, 15 (4) 267; 10.1183/20734735.0310-2019 | |
Interstitial lung diseases: course report Michael Kreuter, Athol Wells, Deval R. Mehta, Anna Kovchun Breathe, 15 (4) 270; 10.1183/20734735.0259-2019 | |
ß2-agonists do not work in children under 2 years of age: myth or maxim? Fatima Yusuf, Andrew P. Prayle, Michael P. Yanney Breathe, 15 (4) 273; 10.1183/20734735.0255-2019 | |
Biomarker development in asthma from a patient's perspective Dominique Hamerlijnck Breathe, 15 (4) 277; 10.1183/20734735.0303-2019 | |
Continuous professional development: elevating thoracic oncology education in Europe Wouter H. van Geffen, Torsten G. Blum, Stefano Aliberti, Kevin G. Blyth, Clementine Bostantzoglou, Amy Farr, Bogdan Grigoriu, Georgia Hardavella, Rudolf M. Huber, Nick Maskell, Gilbert Massard, Najib M. Rahman, Daiana Stolz, Jan van Meerbeeck Breathe, 15 (4) 279; 10.1183/20734735.0296-2019 | |
Hot topics and current controversies in non-cystic fibrosis bronchiectasis Diego Severiche-Bueno, Enrique Gamboa, Luis F. Reyes, Sanjay H. Chotirmall Breathe, 15 (4) 286; 10.1183/20734735.0261-2019 | |
Procalcitonin in respiratory disease: use as a biomarker for diagnosis and guiding antibiotic therapy Andrew W. Creamer, Alice E. Kent, Maha Albur Breathe, 15 (4) 296; 10.1183/20734735.0258-2019 | |
Clinical utility of exhaled nitric oxide fraction in the management of asthma and COPD Steve W. Turner, Anne B. Chang, Ian A. Yang Breathe, 15 (4) 306; 10.1183/20734735.0268-2019 | |
COPD treatment choices based on blood eosinophils: are we there yet? Brian Oliver, Katrina Tonga, David Darley, Sandra Rutting, Xin Zhang, Hui Chen, Gang Wang Breathe, 15 (4) 318; 10.1183/20734735.0254-2019 | |
A Malaysian ex-smoker with cough, breathlessness and nonresolving bronchospasm Jo Anne Lim, Natrajan Caruppaiya, Noriza Zainol Abidin, Boon Tat Khor, Tharmalingam Palanivelu, Sunita Devi Hukam Gopal Chand, Aznita Ibrahim Breathe, 15 (4) 324; 10.1183/20734735.0224-2019 | |
In the spotlight: first ERS Early Career Member Award winner, the ERS Lung Science Conference 2020 and new ECMC members Thomas Janssens, Olivier Burgy, Sara Rolandsson Enes, Jana De Brandt Breathe, 15 (4) 330; 10.1183/20734735.0253-2019 | |
Changes in FEV1 over time in COPD and the importance of spirometry reference ranges: the devil is in the detail Jane Kirkby, Raffaella Nenna, Aisling McGowan Breathe, 15 (4) 337; 10.1183/20734735.0252-2019 | |
Model for predicting EGFR mutation status in lung cancer Lam Nguyen Ho, Thuong Vu Le Breathe, 15 (4) 340; 10.1183/20734735.0250-2019 | |
Could airway basal cells be a novel predictor of mortality in IPF? Louise Organ Breathe, 15 (4) 343; 10.1183/20734735.0265-2019 | |
Management of incidental nodules in lung cancer screening: ready for prime-time? Nikolaos I. Kanellakis, Kevin Lamote Breathe, 15 (4) 346; 10.1183/20734735.0247-2019 | |
Initial inhaler choice in COPD: real-world evidence Thomas Jones Breathe, 15 (4) 350; 10.1183/20734735.0256-2019 | |
Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations? Victor A. Adepoju Breathe, 15 (4) 353; 10.1183/20734735.0257-2019 | |
Assembly 14: clinical techniques, imaging and endoscopy Walter De Wever Breathe, 15 (4) 356; 10.1183/20734735.0218-2019 | |
Pulmonary Embolism
Breathe, 15 (4) 360; 10.1183/20734735.ELF154 | |
Patient testimony: hyper-IgE ?syndrome and associated lung ?infections Rachel Orritt, Sandra Hicks Breathe, 15 (4) e131; 10.1183/20734735.0331-2019 | |
Masterclass in airways disease: course report Antonio Spanevello, Omar Usmani, Batyr R. Osmonov, Kostiantyn Dmytriiev, Kseniia Suska Breathe, 15 (4) e132; 10.1183/20734735.0298-2019 | |
“Procalcitonin in respiratory disease: use as a biomarker for diagnosis and guiding antibiotic therapy” Breathe 2019; 15: 296–304.
Breathe, 15 (4) e152; 10.1183/20734735.5258-2019 | |
The electronic nose: emerging biomarkers in lung cancer diagnostics Wouter H. van Geffen, Kevin Lamote, Adrien Costantini, Lizza E.L. Hendriks, Najib M. Rahman, Torsten G. Blum, Jan van Meerbeeck Breathe, 15 (4) e135; 10.1183/20734735.0309-2019 | |
ERS International Congress 2019: highlights from Best Abstract awardees Lorna E. Latimer, Marieke Duiverman, Mahmoud I. Abdel-Aziz, Gulser Caliskan, Sara M. Mensink-Bout, Alberto Mendoza-Valderrey, Aurelien Justet, Junichi Omura, Karthi Srikanthan, Jana De Brandt Breathe, 15 (4) e143; 10.1183/20734735.0330-2019 | |